#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio
3/20/2024
0:00
27:30
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.
More episodes from "AWS Health Innovation Podcast"
Don't miss an episode of “AWS Health Innovation Podcast” and subscribe to it in the GetPodcast app.